BOSTON & SINGAPORE--(BUSINESS WIRE)--Ora, Inc., the foremost global ophthalmology contract research organization (CRO), today announced a strategic, exclusive partnership with the Singapore Eye ...
Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without ...
WATERLOO, Ontario, April 18, 2023—Scientists from the Centre for Ocular Research & Education (CORE) are poised to unveil multiple advancements in 3D printing next week during the ARVO 2023 Annual ...
While biotech research areas such as obesity drugs—which Morgan Stanley Research upped its 6-year market forecast for by $39 billion this year—have been a focus for institutional investors and hedge ...
Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. Some studies have ...
The University of Utah’s elite H.A. and Edna Benning Medical Society has selected renowned John A. Moran Eye Center researcher Liliana Werner, MD, PhD, for membership as the recipient of one of 15 ...
Healome Therapeutics ('Healome'), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed ...
Advocates for eye and vision research must come together now to thwart attempts by the Trump administration to slash research funding and downgrade and dilute the National Eye Institute (NEI) of the ...
Cannabidiol (CBD) is not recommended for glaucoma because research shows mixed effects on intraocular pressure (IOP), including possible increases that may worsen vision loss. Eye-related side effects ...
Although ocular disease commonly occurs in people with rosacea, ocular rosacea remains underrecognized by dermatologists and even eye specialists, according to experts. Fortunately, an ophthalmologist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results